Multimedia Consumer Products Consumer Healthcare How to Approach M&A Integration to Create a Sustainable Advantage Below is an excerpt from How to Approach M&A Integration to Create a Sustainable Advantage. Download the full eBook at ...
Blog Post Consumer Healthcare Consumer Products Optimizing ERP Integration in Consumer Healthcare M&A Over the last five years, there have been multiple large consumer healthcare transactions between traditional pharmaceutical companies and consumer packaged ...
Blog Post Consumer Products Organizational Performance Mastering the Art of Brand Acquisitions It is no surprise that traditional CPG companies are diversifying and bringing purpose to their brand acquisition strategies: purpose-driven brands ...
Blog Post Consumer Products Consulting Services Critical Issues in M&A Deals Global M&A deals had the strongest start ever in the first half of 2018, totaling $2.5 trillion in value. U.S. ...
Multimedia Consulting Services Consumer Products M&A Due Diligence for the 21st Century As global mergers and acquisitions (M&As) are expected to hit a record $3.2 trillion in 2018 after hitting $2.6 trillion ... Download PDF
Blog Post Consumer Products Food and Beverage M&A Trends: A Healthier Way in Food and Beverage The latest transaction news from the food industry is Nestlé’s sales of their candy business to Ferrero, which is valued ...
Multimedia Consulting Services Biotech Merger Integration – Pharma’s True Bellwether of Success? M&A continues to be a critical tool for growth in the pharmaceutical industry but the last several years has seen ... Download PDF
Blog Post Medical Device Information Technology How Medical Device and Technology Mergers Affect Patient Experience The pricing pressure of healthcare system consolidation and private and government payers has increased the demand for value-based care. This ...
Article Consulting Services Pharma M&A Impact on Service Providers to the Pharmaceutical Industry Although appearing dead for now, the $106 billion associated with Pfizer’s proposed buyout of AstraZeneca makes it hard to ignore ...
